The Sputnik V COVID-19 vaccine has been developed by Moscow’s Gamaleya Research Institute of Epidemiology and Microbiology and it was touted as the “World’s first Coronavirus vaccine” when it received approval for public use in August. (Representational image) COVID-19 vaccine update: In a major boost to the prospects of a Coronavirus vaccine for India, drugmaker … Read more
A group of developing countries, backed by United Nations agencies and activist groups, is pushing to limit patent protections for Covid-19 vaccines being tested by some of the world’s biggest pharmaceutical companies so that inexpensive copies can be produced for poorer nations. South Africa, Ghana, Senegal, Pakistan and others argue they won’t be able to … Read more
The record speed at which pharma companies are developing Covid-19 vaccines has been unprecedented. This month is crucial as many of them will begin to release early trial results of their candidates. This week the trial results on a few treatment options offered hope and disappointment. Vaccine developers also gave a realistic launch deadline for … Read more
A Serum team was in Delhi to meet the officials and subsequently announced that they were halting the trials. Pune-based vaccine maker Serum Institute of India on Thursday halted the ongoing clinical trials of the Covid-19 vaccine in the country. “We are reviewing the situation and pausing India trials till AstraZeneca restarts trials,” a statement issued … Read more
The Oxford vaccine consists of two doses and the second dose is taken 28 days after the first shot. Vaccine maker Serum Institute of India on Wednesday said the ongoing clinical trials in India for the Covid-19 vaccine, developed by University of Oxford and AstraZeneca, will continue and not be affected by AstraZeneca’s announcement of … Read more
India is known globally to produce over 60% of the world’s vaccine. (Representational Image; Courtesy: Reuters)Bangladesh Company Beximco Pharmaceuticals Limited has tied up with Serum Institute of India to produce Covid-19 vaccine; this follows the recent visit of the Indian Foreign Secretary to Dhaka. While welcoming the tie-up between two enterprises, responding to a question … Read more